Literature DB >> 10797266

A human melanoma metastasis-suppressor locus maps to 6q16.3-q23.

M E Miele1, M D Jewett, S F Goldberg, D L Hyatt, C Morelli, F Gualandi, P Rimessi, D J Hicks, B E Weissman, G Barbanti-Brodano, D R Welch.   

Abstract

Loss, deletion or rearrangement along large portions of the long arm (q-arm) of chromosome 6 occurs in >80% of late-stage human melanomas, suggesting that genes controlling malignant characteristics are encoded there. Metastasis, but not tumorigenicity, was completely suppressed in the human melanoma cell line C8161 into which an additional intact chromosome 6 had been introduced by microcell-mediated chromosome transfer. Our objective was to refine the location of a putative metastasis suppressor gene. To do this, we transferred an intact (neo6) and a deletion variant [neo6qdel; neo6(del)(q16.3-q23)] of neomycin-tagged human chromosome 6 into metastatic C8161 subclone 9 (C8161.9) by MMCT. Single cell hybrid clones were selected in G-418 and isolated. Following verification that the hybrids retained the expected regions of chromosome 6 using a panel of polymorphic sequence-tagged sites, the hybrids were tested for tumorigenicity and metastasis in athymic mice. As reported previously, intact, normal chromosome 6 suppressed metastasis whether tumor cells were injected i.v. or into an orthotopic (i.e., intradermal) site. In contrast, metastasis was not suppressed in the neo6qdel hybrids. Tumorigenicity was unaffected in hybrids prepared with either chromosome 6 donor. These data strongly suggest that a human melanoma metastasis suppressor locus maps between 6q16.3-q23 ( approximately 40 cM). Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10797266     DOI: 10.1002/(sici)1097-0215(20000515)86:4<524::aid-ijc13>3.0.co;2-w

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  GWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern development.

Authors:  Mats Larsson; David L Duffy; Gu Zhu; Jimmy Z Liu; Stuart Macgregor; Allan F McRae; Margaret J Wright; Richard A Sturm; David A Mackey; Grant W Montgomery; Nicholas G Martin; Sarah E Medland
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

Authors:  Laura T Smith; Mauting Lin; Romulo M Brena; James C Lang; David E Schuller; Gregory A Otterson; Carl D Morrison; Dominic J Smiraglia; Christoph Plass
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

Review 4.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

Review 5.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

Authors:  Kevin T Nash; Danny R Welch
Journal:  Front Biosci       Date:  2006-01-01

6.  KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha.

Authors:  Ying Jiang; Michael Berk; Lisam Shanjukumar Singh; Haiyan Tan; Lihong Yin; C Thomas Powell; Yan Xu
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.

Authors:  A Barghorn; E J Speel; B Farspour; P Saremaslani; S Schmid; A Perren; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 8.  Chromosomal aberrations related to metastasis of human solid tumors.

Authors:  Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

9.  SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.

Authors:  Xue-Yuan Dong; Carmen Rodriguez; Peng Guo; Xiaodong Sun; Jeffrey T Talbot; Wei Zhou; John Petros; Qunna Li; Robert L Vessella; Adam S Kibel; Victoria L Stevens; Eugenia E Calle; Jin-Tang Dong
Journal:  Hum Mol Genet       Date:  2008-01-17       Impact factor: 6.150

10.  RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function.

Authors:  Reza Rahbari; Mio Kitano; Lisa Zhang; Swaroop Bommareddi; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.